Rexahn Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RNN and buy or sell other stocks, ETFs, and their options commission-free!About RNN
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.
CEOGeorge Magrath, III, MD
CEOGeorge Magrath, III, MD
Employees18
Employees18
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2018
Founded2018
Employees18
Employees18
RNN Key Statistics
Market cap148.45M
Market cap148.45M
Price-Earnings ratio-1.25
Price-Earnings ratio-1.25
Dividend yield—
Dividend yield—
Average volume784.72K
Average volume784.72K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.59
52 Week high$2.59
52 Week low$0.65
52 Week low$0.65
Stock Snapshot
The current Rexahn Pharmaceuticals(RNN) stock price is $2.30, with a market capitalization of 148.45M. The stock trades at a price-to-earnings (P/E) ratio of -1.25.
During the trading day, Rexahn Pharmaceuticals(RNN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 784.72K.
Over the past 52 weeks, Rexahn Pharmaceuticals(RNN) stock has traded between a high of $2.59 and a low of $0.65.
Over the past 52 weeks, Rexahn Pharmaceuticals(RNN) stock has traded between a high of $2.59 and a low of $0.65.